Hoshi Iryosanki Co., Ltd. (JP:7634)

:7634

7634

Hoshi Iryosanki Co., Ltd.

RESEARCH TOOLSreports

Hoshi Iryosanki Co., Ltd. (7634) Price & Analysis

0 Followers

7634 Stock Chart & Stats

¥5110.00

-¥15.00(-0.35%)

At close: Jan 08 4:00 PM EST

¥5110.00

-¥15.00(-0.35%)

Day’s Range― - ―

52-Week Range¥4,365.00 - ¥6,000.00

Previous CloseN/A

Volume400.00

Average Volume (3M)1.10K

Market Cap

¥16.65B

Enterprise Value¥6.92B

Total Cash (Recent Filing)¥10.52B

Total Debt (Recent Filing)¥789.40M

Price to Earnings (P/E)12.2

Beta0.19

Next Earnings

May 11, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.61%

Share Statistics

EPS (TTM)104.46

Shares Outstanding3,420,000

10 Day Avg. Volume1,120

30 Day Avg. Volume1,096

Financial Highlights & Ratios

PEG Ratio2.38

Price to Book (P/B)0.77

Price to Sales (P/S)0.94

P/FCF Ratio8.63

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Strong Balance SheetVery low leverage and a 75% equity ratio give the company durable financial flexibility. This supports capex for product development, sustains service and warranty obligations, and helps absorb demand shocks without needing external financing, strengthening long-term resilience.

Sustained Margins & Revenue HistoryMulti-year revenue growth combined with high gross and solid operating margins indicates durable product economics and operational efficiency. Strong margins enable reinvestment in R&D and service networks, supporting competitive positioning in respiratory medical devices over the medium term.

Strong Cash GenerationRobust FCF growth and healthy OCF-to-net-income conversion show effective cash conversion from operations. That supports funding of after-sales service, parts inventory, and iterative product development internally, reducing reliance on external capital for steady investments.

Bears Say

Recent Revenue DecelerationRecent revenue growth (~2.3%) is materially below the five-year average (~7.2%), suggesting a deceleration in demand or market saturation. If persistent, slower topline growth will constrain reinvestment and margin expansion, making medium-term earnings less predictable.

Modest ROEAn ROE below double digits indicates only moderate efficiency in converting equity into profits. For a capital-intensive medical-equipment firm, this may signal limited returns on incremental investment and could temper long-term shareholder value creation versus higher-return peers.

Customer Concentration / Revenue Mix OpacityHeavy reliance on institutional buyers and unclear split between consumables, services, and product sales raises exposure to hospital procurement cycles and budget timing. Limited diversification in recurring revenue increases volatility in medium-term cashflows and replacement demand.

7634 FAQ

What was Hoshi Iryosanki Co., Ltd.’s price range in the past 12 months?

Hoshi Iryosanki Co., Ltd. lowest stock price was ¥4365.00 and its highest was ¥6000.00 in the past 12 months.

What is Hoshi Iryosanki Co., Ltd.’s market cap?

Hoshi Iryosanki Co., Ltd.’s market cap is ¥16.65B.

When is Hoshi Iryosanki Co., Ltd.’s upcoming earnings report date?

Hoshi Iryosanki Co., Ltd.’s upcoming earnings report date is May 11, 2026 which is in 32 days.

How were Hoshi Iryosanki Co., Ltd.’s earnings last quarter?

Hoshi Iryosanki Co., Ltd. released its earnings results on Feb 09, 2026. The company reported ¥104.46 earnings per share for the quarter, beating the consensus estimate of N/A by ¥104.46.

Is Hoshi Iryosanki Co., Ltd. overvalued?

According to Wall Street analysts Hoshi Iryosanki Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Hoshi Iryosanki Co., Ltd. pay dividends?

Hoshi Iryosanki Co., Ltd. pays a Semiannually dividend of ¥45 which represents an annual dividend yield of 1.61%. See more information on Hoshi Iryosanki Co., Ltd. dividends here

What is Hoshi Iryosanki Co., Ltd.’s EPS estimate?

Hoshi Iryosanki Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Hoshi Iryosanki Co., Ltd. have?

Hoshi Iryosanki Co., Ltd. has 3,420,000 shares outstanding.

What happened to Hoshi Iryosanki Co., Ltd.’s price movement after its last earnings report?

Hoshi Iryosanki Co., Ltd. reported an EPS of ¥104.46 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.806%.

Which hedge fund is a major shareholder of Hoshi Iryosanki Co., Ltd.?

Currently, no hedge funds are holding shares in JP:7634

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Hoshi Iryosanki Co., Ltd.

Hoshi Iryo-Sanki Co., Ltd. manufactures and sells pharmaceutical medical oxygen and nitrous oxides in Japan. It operates in five segments: Medical Gas-Related Business; Home Healthcare-Related Business; Medical Gas Equipment Construction-Related Business; Nursing-Care Related Business; and Facilities Nursing-Related Business. The Medical Gas-Related Business segment sells medical oxygen gas, anesthetic gas, and other medical gas. The Home Healthcare-Related Business segment rents oxygen concentrators for home oxygen therapy; and equipment for continuous positive airway pressure, home ventilators, etc. The Medical Gas Equipment Construction-Related Business segment designs and constructs medical gas piping construction, as well as maintenance and inspection of medical gas piping equipment. The Nursing-Care Related Business segment offers rental and sale of nursing care related products and equipment, home renovation, home-visit nursing, and in-home nursing care support services. The Facilities Nursing-Related Business segment operates fee-based nursing homes and day care facilities, as well as related operations. The company was founded in 1960 and is headquartered in Tokyo, Japan.